
Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial
31/8/2026
0:00
8:31
No Label: Geoff Kerchner, MD, PhD
Dr. Geoff Kerchner, Vice President and Global Head of Neurodegeneration at Roche, Basel, Switzerland, discusses the science behind PrevenTRON, a prevention study evaluating trontinemab in individuals with preclinical Alzheimer disease.
Dr. Geoff Kerchner, Vice President and Global Head of Neurodegeneration at Roche, Basel, Switzerland, discusses the science behind PrevenTRON, a prevention study evaluating trontinemab in individuals with preclinical Alzheimer disease.
Altri episodi di "NeuroFrontiers"



Non perdere nemmeno un episodio di “NeuroFrontiers”. Iscriviti all'app gratuita GetPodcast.








